Over the past 12 months, 0 insiders at Karuna Therapeutics, Inc. filed 0 open-market SEC Form 4 transactions on KRTX: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 8, 24 | Stephen K. BrannanChief Medical Officer | SELL | 4.9K | $318.96 | $1.6M |
| Feb 8, 24 | Stephen K. BrannanChief Medical Officer | SELL | 4.2K | $316.56 | $1.3M |
| Jan 8, 24 | Stephen K. BrannanChief Medical Officer | SELL | 15.0K | $316.81 | $4.8M |
| Dec 8, 23 | Stephen K. BrannanChief Medical Officer | SELL | 4.0K | $204.18 | $805K |
| Nov 8, 23 | Stephen K. BrannanChief Medical Officer | SELL | 2.2K | $180.08 | $404K |
| Oct 9, 23 | Stephen K. BrannanChief Medical Officer | SELL | 3.3K | $173.77 | $563K |
| Sep 8, 23 | Stephen K. BrannanChief Medical Officer | SELL | 2.8K | $185.60 | $507K |
| Sep 1, 23 | Jeffrey M JonasDirector | SELL | 8.4K | $188.98 | $1.6M |
| Aug 22, 23 | Troy A. IgnelziChief Financial Officer | SELL | 855 | $176.60 | $150K |
| Aug 8, 23 | Stephen K. BrannanChief Medical Officer | SELL | 2.4K | $181.50 | $430K |
| Aug 1, 23 | Jeffrey M JonasDirector | SELL | 6.3K | $198.41 | $1.2M |
| Jul 3, 23 | Jeffrey M JonasDirector | SELL | 8.0K | $217.82 | $1.7M |
| Jul 3, 23 | Laurie J OlsonDirector | SELL | 600 | $216.03 | $129K |
| May 23, 23 | Troy A. IgnelziChief Financial Officer | SELL | 3.3K | $225.93 | $739K |
| Apr 20, 23 | Andrew Craig MillerChief Operating Officer | SELL | 15.0K | $200.13 | $3.0M |
| Apr 18, 23 | Andrew Craig MillerChief Operating Officer | SELL | 30.0K | $200.16 | $6.0M |
| Apr 10, 23 | Stephen K. BrannanChief Medical Officer | SELL | 5.0K | $176.88 | $884K |
| Apr 3, 23 | Laurie J OlsonDirector | SELL | 1.0K | $181.02 | $181K |
| Mar 9, 23 | Stephen K. BrannanChief Medical Officer | SELL | 5.0K | $189.51 | $948K |
| Feb 21, 23 | Troy A. IgnelziChief Financial Officer | SELL | 6.0K | $190.01 | $1.1M |
| Feb 9, 23 | Stephen K. BrannanChief Medical Officer | SELL | 5.0K | $192.37 | $962K |
| Jan 18, 23 | Troy A. IgnelziChief Financial Officer | SELL | 200 | $200.14 | $40K |
| Jan 17, 23 | Troy A. IgnelziChief Financial Officer | SELL | 817 | $201.41 | $165K |
| Jan 13, 23 | James HealyDirector | SELL | 6.0K | $199.90 | $1.2M |
| Jan 9, 23 | Stephen K. BrannanChief Medical Officer | SELL | 3.5K | $197.52 | $686K |
| Jan 3, 23 | Laurie J OlsonDirector | SELL | 1.0K | $197.48 | $197K |
| Dec 9, 22 | Stephen K. BrannanChief Medical Officer | SELL | 3.6K | $200.76 | $730K |
| Dec 1, 22 | Andrew Craig MillerChief Operating Officer | SELL | 15.0K | $228.30 | $3.4M |
| Nov 15, 22 | Troy A. IgnelziChief Financial Officer | SELL | 16.5K | $225.85 | $3.7M |
| Nov 10, 22 | Andrew Craig MillerChief Operating Officer | SELL | 15.0K | $225.98 | $3.4M |
| Nov 9, 22 | Stephen K. BrannanChief Medical Officer | SELL | 5.0K | $216.00 | $1.1M |
| Nov 1, 22 | Andrew Craig MillerChief Operating Officer | SELL | 15.0K | $225.08 | $3.4M |
| Oct 11, 22 | Laurie J OlsonDirector | SELL | 1.0K | $205.63 | $206K |
| Oct 10, 22 | Stephen K. BrannanChief Medical Officer | SELL | 5.0K | $207.51 | $1.0M |
| Oct 4, 22 | Troy A. IgnelziChief Financial Officer | SELL | 400 | $233.20 | $93K |
| Oct 3, 22 | Troy A. IgnelziChief Financial Officer | SELL | 2.0K | $232.00 | $463K |
| Sep 30, 22 | Troy A. IgnelziChief Financial Officer | SELL | 5.2K | $230.49 | $1.2M |
| Sep 9, 22 | Stephen K. BrannanChief Medical Officer | SELL | 5.0K | $243.46 | $1.2M |
| Aug 15, 22 | Laurie J OlsonDirector | SELL | 1.0K | $267.59 | $268K |
| Aug 9, 22 | Stephen K. BrannanChief Medical Officer | SELL | 12.3K | $228.13 | $2.8M |
| Aug 9, 22 | Troy A. IgnelziChief Financial Officer | SELL | 16.5K | $227.83 | $3.8M |
| Jul 11, 22 | Stephen K. BrannanChief Medical Officer | SELL | 15.0K | $133.29 | $2.0M |
| Jun 30, 22 | James HealyDirector | BUY | 48.1K | $123.39 | $5.9M |
| Jun 29, 22 | James HealyDirector | BUY | 27.8K | $125.00 | $3.4M |
| Jun 9, 22 | Stephen K. BrannanChief Medical Officer | SELL | 5.0K | $110.90 | $555K |
| May 27, 22 | Laurie J OlsonDirector | SELL | 1.0K | $110.00 | $110K |
| May 9, 22 | Stephen K. BrannanChief Medical Officer | SELL | 5.0K | $104.10 | $521K |
| Apr 21, 22 | Troy A. IgnelziChief Financial Officer | SELL | 40 | $134.46 | $5K |
| Apr 20, 22 | Troy A. IgnelziChief Financial Officer | SELL | 704 | $133.20 | $94K |
| Apr 19, 22 | Troy A. IgnelziChief Financial Officer | SELL | 3.5K | $130.81 | $458K |
Over the past 12 months, insiders at Karuna Therapeutics, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on KRTX, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market KRTX insider purchase in our data was $5.9M by James Healy, Director, filed on Jun 30, 22.
0 different insiders at Karuna Therapeutics, Inc. filed open-market SEC Form 4 transactions on KRTX over the last 12 months.
InsiderTape plots every KRTX insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Karuna Therapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →